product image
Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Feb 14, 2020

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay USD 20 for each share in cash for ...

Read More
product image
Notizia

Feb 6, 2020

FDA gives thumbs-up to Balversa The U.S. FDA has granted approval of Balversa (erdafitinib) to Belgium-based Janssen Pharmaceutica, for the treatment of advanced or metasta...

Read More
product image
Notizia

Apr 16, 2020

Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients aged three years and above sufferin...

Read More
product image
Notizia

Feb 6, 2020

Stemline gives in-licenses global rights to SL-1001 Stemline Therapeutics, Inc. is a biopharmaceutical company focused on development and commercialization of novel oncolog...

Read More
product image
A helping hand in treatment of CRC

Feb 5, 2020

Patients suffering from Colorectal Cancer (CRC) usually gets affected with distant organ metastases spreading the tumor to other parts of the body. Patients with unresectab...

Read More
product image
Neuroendocrine tumors (NETs): The complex group of tumors

Jul 2, 2020

Neuroendocrine tumors (NETs) consists of complex group of tumors that develop predominantly in the digestive or respiratory tracts, but can occur in many areas of the body....

Read More
product image
4D Molecular Therapeutics raises; Arvinas slates for IPO; Sutro ruminates for $ 75M; Emergent BioSolutions remunerates Narcan maker

Jun 19, 2020

Gene therapy company 4D Molecular Therapeutics raises USD 90 Million to collaborate with AstraZeneca and Roche for moving gene therapies into clinical testing 4D Molecular ...

Read More
product image
Japan Manages to Stand Apart from Global Hepato Cellular Carcinoma Crowd

Feb 5, 2020

Hepato Cellular Carcinoma (HCC) Not all deadly battles are lost. Some are won too.It is without the slightest doubt that the ones won are the typical examples of smart mana...

Read More
product image
AZ dragout Entasis; Sierra remunerates Gilead; Principia raises; Harbour BioMed and Kelun pen deal

Jun 19, 2020

AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out to raise up to USD 86 Million thro...

Read More
product image
Snippet

Feb 14, 2020

HOA Puts into Operation of Updated CyberKnife Version Cancer patients now have a solid reason to cheer, as US-based Hematology-Oncology Associates (HOA) lately came up with...

Read More
product image
NOTIZIA

Feb 7, 2020

British scientists looking forward to treat Alzheimer’s disease through diabetes drug A group of British scientists are looking for the treatment of Alzheimer’s disease...

Read More
product image
Fatty Acid Amide Hydrolase (FAAH) Inhibitors – Pipeline Insights, 2015 – A DelveInsight’s Report

Jun 25, 2020

Fatty acid amide hydrolase (FAAH) is an intracellular amidase signature family of serine hydrolases enzyme, which catalyzes the hydrolysis of bioactive fatty acid ethanolam...

Read More